|
BRIEF-Vectura says in US collaboration agreement for VR506 asthma therapy
Reuters Announces a further US collaboration agreement with a leading international pharmaceutical company for VR506 asthma therapy. * Vectura's partner will be responsible for commercialisation and manufacture of product together with clinical development … |
View full post on asthma – Google News